James K. Gierse
Pfizer Global Research and Development
700 Chesterfield Village Parkway N.
Chesterfield
Missouri 63198
United States
Name/email consistency: high
- Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors. Gierse, J., Nickols, M., Leahy, K., Warner, J., Zhang, Y., Cortes-Burgos, L., Carter, J., Seibert, K., Masferrer, J. Eur. J. Pharmacol. (2008)
- Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity. Gierse, J.K., Zhang, Y., Hood, W.F., Walker, M.C., Trigg, J.S., Maziasz, T.J., Koboldt, C.M., Muhammad, J.L., Zweifel, B.S., Masferrer, J.L., Isakson, P.C., Seibert, K. J. Pharmacol. Exp. Ther. (2005)